NCT06421597View on ClinicalTrials.gov

Identifying Individuals At Risk of Glucocorticoid-Induced Impairment of Bone Disease

PHASE2RecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 4, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Osteoporosis Secondary
Interventions
DRUG

Prednisolone

prednisoline 25 mg/day for seven days

DRUG

Placebo

Placebo treatment for seven days

Trial Locations (2)

5000

RECRUITING

Odense University Hospital, Odense C

6700

NOT_YET_RECRUITING

Hospital of South West Jutland, Esbjerg

All Listed Sponsors
collaborator

Esbjerg Hospital - University Hospital of Southern Denmark

OTHER

collaborator

University of Ulm

OTHER

collaborator

University of Birmingham

OTHER

lead

Odense University Hospital

OTHER